HCFA Joins Private Payers On Electrical Stimulation Coverage Conditions
This article was originally published in The Gray Sheet
Executive Summary
Electrical bone growth stimulators will be reimbursed for patients whose fractures demonstrate no radiographic signs of healing over a three-month period, according to a coverage policy revision issued Nov. 9 by the Health Care Financing Administration.
You may also be interested in...
MCAC Review Unnecessary For Fracture Healing Electrical Stimulation Policy
The Health Care Financing Administration is not planning to seek a recommendation on electrical stimulation for fracture healing from its Medicare Coverage Advisory Committee before making a national policy decision, agency staffers report.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.